A detailed history of Israel Englander (Millennium Management LLC) transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Millennium Management LLC holds 365,200 shares of TMO stock, worth $187 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
365,200
Previous 343,700 6.26%
Holding current value
$187 Million
Previous $190 Million 18.85%
% of portfolio
0.11%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$531.86 - $624.21 $236 Million - $276 Million
-442,945 Reduced 78.34%
122,476 $75.8 Million
Q2 2024

Aug 14, 2024

BUY
$541.52 - $599.02 $285 Million - $315 Million
526,364 Added 1347.68%
565,421 $313 Million
Q1 2024

May 15, 2024

SELL
$528.82 - $599.43 $48.4 Million - $54.9 Million
-91,513 Reduced 70.09%
39,057 $22.7 Million
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $61.3 Million - $75.8 Million
-142,169 Reduced 52.13%
130,570 $69.3 Million
Q2 2023

Aug 14, 2023

BUY
$508.46 - $591.13 $96.7 Million - $112 Million
190,278 Added 230.75%
272,739 $142 Million
Q1 2023

May 15, 2023

BUY
$535.0 - $604.82 $43.8 Million - $49.5 Million
81,887 Added 14266.03%
82,461 $47.5 Million
Q4 2022

Feb 14, 2023

SELL
$484.71 - $571.37 $9.46 Million - $11.1 Million
-19,509 Reduced 97.14%
574 $316,000
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $26.8 Million - $32 Million
-52,907 Reduced 72.49%
20,083 $10.2 Million
Q2 2022

Aug 15, 2022

SELL
$500.9 - $612.21 $1.51 Million - $1.84 Million
-3,006 Reduced 3.96%
72,990 $39.7 Million
Q1 2022

May 16, 2022

SELL
$524.0 - $644.92 $20.3 Million - $25 Million
-38,700 Reduced 33.74%
75,996 $44.9 Million
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $33 Million - $38.7 Million
-58,059 Reduced 33.61%
114,696 $76.5 Million
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $17.5 Million - $20.9 Million
-34,331 Reduced 16.58%
172,755 $98.7 Million
Q2 2021

Aug 16, 2021

SELL
$441.0 - $508.24 $175 Million - $201 Million
-396,199 Reduced 65.67%
207,086 $104 Million
Q1 2021

May 17, 2021

BUY
$439.85 - $518.83 $43 Million - $50.7 Million
97,674 Added 19.32%
603,285 $275 Million
Q4 2020

Feb 16, 2021

BUY
$435.06 - $527.66 $133 Million - $162 Million
306,074 Added 153.39%
505,611 $236 Million
Q3 2020

Nov 16, 2020

BUY
$359.77 - $441.52 $37.2 Million - $45.7 Million
103,406 Added 107.57%
199,537 $88.1 Million
Q2 2020

Aug 14, 2020

BUY
$275.2 - $362.34 $22.8 Million - $30.1 Million
82,996 Added 631.87%
96,131 $34.8 Million
Q1 2020

May 14, 2020

BUY
$255.3 - $340.05 $1.04 Million - $1.39 Million
4,092 Added 45.25%
13,135 $3.73 Million
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $176,754 - $213,226
-650 Reduced 6.71%
9,043 $2.94 Million
Q3 2019

Nov 14, 2019

SELL
$268.46 - $305.43 $117 Million - $133 Million
-434,639 Reduced 97.82%
9,693 $2.82 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $33.7 Million - $38.7 Million
-130,821 Reduced 22.75%
444,332 $130 Million
Q1 2019

May 14, 2019

BUY
$212.17 - $273.72 $6.68 Million - $8.62 Million
31,502 Added 5.79%
575,153 $157 Million
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $94.3 Million - $114 Million
452,552 Added 496.77%
543,651 $122 Million
Q3 2018

Nov 14, 2018

SELL
$205.57 - $244.32 $90.1 Million - $107 Million
-438,157 Reduced 82.79%
91,099 $22.2 Million
Q2 2018

Aug 14, 2018

SELL
$203.14 - $219.53 $14.3 Million - $15.4 Million
-70,367 Reduced 11.74%
529,256 $110 Million
Q1 2018

May 15, 2018

BUY
$192.98 - $224.11 $109 Million - $127 Million
566,523 Added 1711.55%
599,623 $124 Million
Q4 2017

Feb 14, 2018

SELL
$182.03 - $200.37 $69.8 Million - $76.9 Million
-383,584 Reduced 92.06%
33,100 $6.29 Million
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $71.6 Million - $80.9 Million
416,684
416,684 $78.8 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.